Lapatinib: An oral dual tyrosine kinase inhibitor for HER-2-positive breast cancer

Sagar D. Sardesai, Anna Maria Storniolo

Research output: Contribution to journalReview article

4 Scopus citations

Fingerprint Dive into the research topics of 'Lapatinib: An oral dual tyrosine kinase inhibitor for HER-2-positive breast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences